UPDATE : Monday, September 7, 2020
상단여백
3 Korean startups using AI to develop new drugs
Korea’s biopharmaceutical industry is increasingly adopting artificial inte...
by Marian Chu  |  2017-12-15 23:00
라인
Corestem’s NeuroNata-R marks increase in foreign patients
The number of foreign patients visiting Korea to use Corestem’s NeuroNata-R...
by Lee Han-soo  |  2017-12-15 16:22
라인
Critical care for sepsis limited in Korea despite high mortality
As patients with sepsis have a high chance of death at upper 30 percent lev...
by Kwak Sung-sun  |  2017-12-15 15:39
라인
Medytox, Hugel compete in botulinum toxin market
Medytox and Hugel have achieved a rapid growth in manufacturing botulinum t...
by So Jae-hyeon  |  2017-12-15 15:12
라인
Korea, China agree to cooperate on healthcare
The Ministry of Health and Welfare said Thursday that it has signed a revis...
by Lee Han-soo  |  2017-12-15 14:24
라인
Parkinson’s disease treatment Azilect in robust growth
Lundbeck Korea’s Azilect (ingredient: rasagiline) is performing well in Kor...
by So Jae-hyeon  |  2017-12-15 11:36
라인
60% approve expanded health coverage, oppose higher premiums: survey
Six out of 10 people approve of the new government policy to cover almost a...
by Marian Chu  |  2017-12-14 17:45
라인
FDA approves Pfizer’s Remicade biosimilar
Pfizer said Wednesday that it received U.S. Food and Drug Administration’s ...
by Lee Han-soo  |  2017-12-14 17:16
라인
Korea launches mobile hospital to deploy emergency medical aid
The government Thursday launched a mobile hospital in Cheonan, South Chungc...
by Marian Chu  |  2017-12-14 16:56
라인
Hironic wins ministry certification for Q-Fit
Hironic, a Korean medical device company, said Thursday that it has receive...
by Lee Han-soo  |  2017-12-14 15:14
라인
University professors sign petition against abortion law
College professors from various theological fields Thursday called for abol...
by Marian Chu  |  2017-12-14 15:03
라인
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
Ildong Pharmaceutical and Abbot Korea are likely to try on the rosuvastatin...
by Lee Hye-seon  |  2017-12-14 15:01
라인
‘More accurate diagnosis of preeclampsia possible’
Preeclampsia is one of the top three risks of pregnancy with premature obst...
by Park Gi-taek  |  2017-12-14 11:38
라인
‘New cancer drugs need 601 days to get insurance in Korea’
Newly approved cancer drugs need at least 601 days to receive insurance ben...
by So Jae-hyeon  |  2017-12-14 11:27
라인
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-12-14 10:52
라인
Koreans in their 20s most susceptible to hepatitis A: study
New research shows nine out of 10 young adults in Korea do not have antibod...
by Marian Chu  |  2017-12-13 18:18
라인
MGmed to change name to Cancer Rop
Korean pharmaceutical MGmed decided to change the company’s name to Cancer ...
by Marian Chu  |  2017-12-13 18:14
라인
[Column] Look ahead 10 years before investing
It is said that waiting is the answer when it comes to new drugs that usual...
by Song Hyoung-gon  |  2017-12-13 17:48
라인
Syntekabio, CJ Healthcare agree to develop new drugs using AI
Syntekabio and CJ Healthcare have signed an agreement to co-develop a new i...
by Lee Han-soo  |  2017-12-13 17:17
라인
Daewoong’s liver drug Ursa to enter US market
Daewoong Pharmaceutical said it aimed to sell its flagship product Ursa, a ...
by So Jae-hyeon  |  2017-12-13 15:23
-이전251252253254255256257258259260-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top